Biology, asked by virus8775, 1 year ago

Expression of the uptake drug transporter hoct1 is animportant clinical determinant of the response to imatinib in chronic myeloid leukemia

Answers

Answered by Anonymous
5

☆Some chronic myeloid leukemia(CML) patients do not respond to imatinib, whereas others lose an initialresponse.


Ritiksuglan: hi genius
Similar questions